Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040962 · ClinicalTrials.gov registry record
Fall Risk Assessment in People With Diabetic Neuropathy
A clinical trial of Diabetic Peripheral Neuropathy, sponsored by Stephen D. Jernigan, PT, PhD.
- Completed
- Registry status
- 37
- Enrollment target
- 2
- Study locations
NCT01040962: Completed study of Diabetic Peripheral Neuropathy, sponsored by Stephen D. Jernigan, PT, PhD.
NCT01040962 is a study of Diabetic Peripheral Neuropathy that has completed, run by Stephen D. Jernigan, PT, PhD. The registered enrollment target is 37 participants, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01040962, a study of Diabetic Peripheral Neuropathy, has completed, sponsored by Stephen D. Jernigan, PT, PhD.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
Fall risk is increased in people with diabetic peripheral neuropathy (DPN) and yet, minimal research has been conducted to identify appropriate fall risk assessment tools and improve our understanding of falls in these individuals. Purpose: The primary purpose of this study is to establish a foundation of knowledge needed to address falls in people with DPN. This will be accomplished through 1) comparing the validity of 4 fall risk assessment tools, 2) identifying risk factors for falls and 3) determining how quality of life is influenced by factors related to falls in people with DPN.
Conditions Studied
Study Locations (2)
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- North Kansas City Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-12 |
What the finished NCT01040962 record still lists
NCT01040962 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Diabetic Peripheral Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT01040962 reports a single indexed study location in Kansas, Missouri.
Frequently Asked Questions
What is clinical trial NCT01040962 about?
NCT01040962 is a clinical study titled "Fall Risk Assessment in People With Diabetic Neuropathy". Fall risk is increased in people with diabetic peripheral neuropathy (DPN) and yet, minimal research has been conducted to identify appropriate fall risk assessment tools and improve our understanding of falls in these individuals. Purpose: The primary purpose of this study is to establish a foundat...
What is the current status of trial NCT01040962?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2008-08. Estimated completion is 2010-12.
What conditions does trial NCT01040962 study?
This clinical trial studies the following conditions: Diabetic Peripheral Neuropathy.
Who is sponsoring clinical trial NCT01040962?
This trial is sponsored by Stephen D. Jernigan, PT, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040962 being conducted?
This trial has 2 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01040962's enrollment target sits among peer trials
37 16th of 17 higher than 2 of 17 other Diabetic Peripheral Neuropathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Peripheral Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Walking Function in Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Balance Control and Recovery in Diabetes Peripheral Neuropathy
RECRUITING · NA
-
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia